Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
48,741,370
-
Share change
-
+237,652
-
Total reported value
-
$1,337,077,221
-
Put/Call ratio
-
134%
-
Price per share
-
$27.40
-
Number of holders
-
157
-
Value change
-
-$18,585,145
-
Number of buys
-
97
-
Number of sells
-
70
Institutional Holders of DIPLOMAT PHARMACY INC - COM (DPLO) as of Q1 2016
As of 31 Mar 2016,
DIPLOMAT PHARMACY INC - COM (DPLO) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,741,370 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, BlackRock Fund Advisors, ALLIANCEBERNSTEIN L.P., Cambridge Investment Research Advisors, Inc., BAMCO INC /NY/, Capital World Investors, and WADDELL & REED FINANCIAL INC.
This page lists
157
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.